Literature DB >> 22500685

Multimodal treatment strategies for locally advanced rectal cancer.

Georg F Weber1, Robert Rosenberg, Janet E Murphy, Christian Meyer zum Büschenfelde, Helmut Friess.   

Abstract

This review outlines the important multimodal treatment issues associated with locally advanced rectal cancer. Changes to chemotherapy and radiation schema, as well as modern surgical approaches, have led to a revolution in the management of this disease but the morbidity and mortality remains high. Adequate treatment is dependent on precise preoperative staging modalities. Advances in staging via endorectal ultrasound, computed tomography, MRI and PET have improved pretreatment triage and management. Important prognostic factors and their impact for this disease are under investigation. Here we discuss the different treatment options including modern tumor-related surgical approaches, neoadjuvant as well as adjuvant therapies. Further clinical progress will largely depend on the broader implementation of multidisciplinary treatment strategies following the principles of evidence-based medicine.

Entities:  

Mesh:

Year:  2012        PMID: 22500685     DOI: 10.1586/era.12.3

Source DB:  PubMed          Journal:  Expert Rev Anticancer Ther        ISSN: 1473-7140            Impact factor:   4.512


  6 in total

1.  MRI volumetry for prediction of tumour response to neoadjuvant chemotherapy followed by chemoradiotherapy in locally advanced rectal cancer.

Authors:  T Seierstad; K H Hole; K K Grøholt; S Dueland; A H Ree; K Flatmark; K R Redalen
Journal:  Br J Radiol       Date:  2015-04-22       Impact factor: 3.039

2.  Calreticulin is an effective immunologic adjuvant to tumor-associated antigens.

Authors:  Jun Wang; Zhi Peng Gao; Song Qin; Chang Bai Liu; Li Li Zou
Journal:  Exp Ther Med       Date:  2017-08-22       Impact factor: 2.447

3.  hcrcn81 promotes cell proliferation through Wnt signaling pathway in colorectal cancer.

Authors:  Yao Chen; Tingting Jiang; Lihong Shi; Kunyan He
Journal:  Med Oncol       Date:  2015-11-25       Impact factor: 3.064

4.  The key role of calreticulin in immunomodulation induced by chemotherapeutic agents.

Authors:  Yoshiyuki Yamamura; Takahiro Tsuchikawa; Kengo Miyauchi; Shintaro Takeuchi; Masataka Wada; Toshihiko Kuwatani; Noriaki Kyogoku; Aki Kuroda; Takehiro Maki; Toshiaki Shichinohe; Satoshi Hirano
Journal:  Int J Clin Oncol       Date:  2014-06-28       Impact factor: 3.402

5.  TAGLN suppresses proliferation and invasion, and induces apoptosis of colorectal carcinoma cells.

Authors:  Qinmin Li; Ruihua Shi; Yundong Wang; Xiaoping Niu
Journal:  Tumour Biol       Date:  2012-11-09

6.  Long-term outcomes of transanal endoscopic microsurgery for clinical complete response after neoadjuvant treatment in T2-3 rectal cancer.

Authors:  Javier Ernesto Barreras González; Haslen Cáceres Lavernia; Jorge Gerardo Pereira Fraga; Solvey Quesada Lemus
Journal:  Surg Endosc       Date:  2021-07-06       Impact factor: 4.584

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.